Drug Trials Snapshot: ALYFTREK
Summary
ALYFTREK is a medication for the treatment of cystic fibrosis (CF) in patients 6 years of age and older who have at least one F508del mutation or another respon...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.